AstraZeneca Pharma India Ltd.

NSE: ASTRAZEN | BSE: 506820 | ISIN: INE203A01020 | Industry: Pharmaceuticals
| Expensive Star
8945.0000 -129.50 (-1.43%)
NSE Sep 19, 2025 13:32 PM
Volume: 12,512
 

logo
AstraZeneca Pharma India Ltd.
edited 26 Nov 2020
8945.00
-1.43%
Serum Institute may conduct more tests to get half-dose efficacy
Serum Institute may conduct more tests to get half-dose efficacy
Moneycontrol
Preliminary results on the AstraZeneca vaccine were based on a total of 131 COVID-19 cases in a study involving 11,636 participants.
Number of MF schemes increased from 53 to 60 in Jun 2025 qtr.
Sputnik V to AstraZeneca: 'Combine your vaccine with ours to boost efficacy'
Business Today | 27 Nov 2020 9 more
More from AstraZeneca Pharma India Ltd.
Recommended
Market trades lower, Centre states no objection to Vodafone Idea AGR plea
Trendlyne Marketwatch | 19 Sep 2025, 01:21PM
Bull run fizzles out: Multibagger count in Indian equities falls
The Baseline | 18 Sep 2025, 03:38PM
From gems to gadgets: India’s $24 billion leap into global smartphone manufacturing
The Baseline | 17 Sep 2025, 06:26PM